首页> Leukemia and lymphoma> Estimating long-term outcomes in classic Hodgkin lymphoma: a United States population-based oncology simulation model based on overall survival from the ECHELON-1 trial

Estimating long-term outcomes in classic Hodgkin lymphoma: a United States population-based oncology simulation model based on overall survival from the ECHELON-1 trial

导出原文传递

翻译打印收藏纠错

第一作者： Phillips, Tycel

作者： Phillips, Tycel ^[1] ; Migliaccio-Walle, Kristen ^[2] ; Yu, Kristina S. ^[3] ; Bloudek, Brian ; Liu, Nicholas ; Fanale, Michelle ; Burke, John M.

作者单位： Seagen Inc ^[1] Curta Inc ^[2] US Oncol Hematol Res Program,Rocky Mt Canc Ctr ^[3]

关键词 Epidemiology brentuximab vedotin classic Hodgkin lymphoma simulation model frontline secondary cancer HEMATOPOIETIC-CELL TRANSPLANTATION BRENTUXIMAB VEDOTIN OPEN-LABEL FOLLOW-UP RISK CHEMOTHERAPY NIVOLUMAB RELAPSE UPDATE SCAN

发布时间 2023-10-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Leukemia and lymphoma

2023年64卷5/6期

1017-1025页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

点击下载本期目录封面

Leukemia and lymphoma

2023年64卷5/6期

1017-1025页

检索历史清除

Estimating long-term outcomes in classic Hodgkin lymphoma: a United States population-based oncology simulation model based on overall survival from the ECHELON-1 trial

Leukemia and lymphoma

相似文献

同项目论文

Leukemia and lymphoma

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Estimating long-term outcomes in classic Hodgkin lymphoma: a United States population-based oncology simulation model based on overall survival from the ECHELON-1 trial

Leukemia and lymphoma

相似文献

同项目论文

Leukemia and lymphoma

相关期刊

检索历史清除